<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: GlaxoSmithKline shares rally and buck the FTSE trend	</title>
	<atom:link href="https://ukinvestormagazine.co.uk/glaxosmithkline-shares-rally-and-buck-the-ftse-trend/feed/" rel="self" type="application/rss+xml" />
	<link>https://ukinvestormagazine.co.uk/glaxosmithkline-shares-rally-and-buck-the-ftse-trend/</link>
	<description>UK Investor Magazine provides breaking financial news and investment ideas</description>
	<lastBuildDate>Mon, 02 Jul 2018 10:40:03 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.2</generator>
	<item>
		<title>
		By: AstraZeneca shares drop after new cancer treatment approval - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/glaxosmithkline-shares-rally-and-buck-the-ftse-trend/#comment-8301</link>

		<dc:creator><![CDATA[AstraZeneca shares drop after new cancer treatment approval - UK Investor Magazine]]></dc:creator>
		<pubDate>Mon, 02 Jul 2018 10:40:03 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=12429#comment-8301</guid>

					<description><![CDATA[[&#8230;] price targets following a year of under-performance against the FTSE 100, though they and GlaxoSmithKline outperformed their FTSE counterparts this weekend. Astra is up just 0.8 percent over the past 52 [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] price targets following a year of under-performance against the FTSE 100, though they and GlaxoSmithKline outperformed their FTSE counterparts this weekend. Astra is up just 0.8 percent over the past 52 [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: Ergomed shares dip on contract delays - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/glaxosmithkline-shares-rally-and-buck-the-ftse-trend/#comment-8297</link>

		<dc:creator><![CDATA[Ergomed shares dip on contract delays - UK Investor Magazine]]></dc:creator>
		<pubDate>Thu, 28 Jun 2018 14:32:19 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=12429#comment-8297</guid>

					<description><![CDATA[[&#8230;] Both the firm and the broker analysing them were equivocal in response to the delays, and the company&#8217;s next course of action. They certainly appear less proactive than their larger counterparts. [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] Both the firm and the broker analysing them were equivocal in response to the delays, and the company&#8217;s next course of action. They certainly appear less proactive than their larger counterparts. [&#8230;]</p>
]]></content:encoded>
		
			</item>
	</channel>
</rss>
